Patents by Inventor Gema ÁLVAREZ GARCÍA

Gema ÁLVAREZ GARCÍA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • vaccine composition
    Patent number: 10864260
    Abstract: The present invention relates to new protein compositions, methods for producing said protein compositions, pharmaceutical compositions comprising said protein compositions and methods for treating infections caused by Neospora caninum. In particular, the present invention relates to a protein composition comprising the proteins specified in Table A in an amount of at least about 2 times (fold change) higher than the same protein present in the whole tachyzoite, as calculated by quantitative label-free liquid chromatography-tandem mass spectrometry (LC-MS/MS).
    Type: Grant
    Filed: October 28, 2016
    Date of Patent: December 15, 2020
    Assignee: UNIVERSIDAD COMPLUTENSE DE MADRID
    Inventors: Javier Regidor Cerrillo, David Arranz Solís, Esther Collantes Fernández, Gema Álvarez García, Luis Miguel Ortega Mora
  • NEOSPORA VACCINE COMPOSITION
    Publication number: 20180311332
    Abstract: The present invention relates to new protein compositions, methods for producing said protein compositions, pharmaceutical compositions comprising said protein compositions and methods for treating infections caused by Neospora caninum. In particular, the present invention relates to a protein composition comprising the proteins specified in Table A in an amount of at least about 2 times (fold change) higher than the same protein present in the whole tachyzoite, as calculated by quantitative label-free liquid chromatography-tandem mass spectrometry (LC-MS/MS).
    Type: Application
    Filed: October 28, 2016
    Publication date: November 1, 2018
    Inventors: Javier REGIDOR CERRILLO, David ARRANZ SOLÍS, Esther COLLANTES FERNÁNDEZ, Gema ÁLVAREZ GARCÍA, Luis Miguel ORTEGA MORA
  • VIRULENT ISOLATE OF NEOSPORA CANINUM AND ITS USES
    Publication number: 20120269823
    Abstract: The present invention relates to a new isolate of Neospora caninum and to the extracts which may be produced therefrom. Said isolate presents a high degree of attenuation, which makes it suitable for the development of vaccines against neosporosis, and of diagnostic tests to detect infection by Neospora caninum in animals. It also describes pharmaceutical compositions wherein said isolate or extracts thereof are used for the prevention and treatment of the infections caused by Neospora caninum in animals.
    Type: Application
    Filed: December 20, 2006
    Publication date: October 25, 2012
    Applicant: LABORATORIOS HIPRA, S.A.
    Inventors: Luis Miguel Ortega Mora, Esther Collantes Fernandez, Silvia Rojo Montejo, Gema Alvarez Garcia, Javier Regidor Cerrillo